The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An Introduction to the Scientific Issues
Open accessAbstract
Advances in dose/volume/outcome (or normal tissue complication probability, NTCP) modeling since the seminal Emami paper from 1991 are reviewed. There has been some progress with an increasing number of studies on large patient samples with three-dimensional dosimetry. Nevertheless, NTCP models are not ideal. Issues related to the grading of side effects, selection of appropriate statistical methods, testing of internal and external model validity, and quantification of predictive power and statistical uncertainty, all limit the usefulness of much of the published literature. Synthesis (meta-analysis) of data from multiple studies is often impossible due to sub-optimal primary analysis, insufficient reporting and variations in the models and predictors analyzed. Clinical limitations to the current knowledge-base includes the need for more data on the effect of patient-related co-factors, interactions between dose-distribution and cytotoxic or molecular targeted agents, and the effect of dose fractions and overall treatment time in relation to non-uniform dose distributions. Research priorities for the next 5 to 10 years are proposed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tolerance of normal tissue to therapeutic irradiation
Emami, B., Lyman, J., Brown, A., Cola, L., Goitein, M., Munzenrider, J. E., Shank, B., Solin, L. J., & Wesson, M. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90171-y · Cited by 4,488
Fitting of normal tissue tolerance data to an analytic function
Burman, C., Kutcher, G. J., Emami, B., & Goitein, M. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90172-z · Cited by 1,249
Complication Probability as Assessed from Dose-Volume Histograms
Lyman, J. T. (1985) · Radiation Research · doi:10.2307/3576626 · Cited by 1,160
Bentzen, S. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1950 · Cited by 1,096
Self-citationJoiner, M. C., & van der Kogel, A. (2009) · CRC Press eBooks · doi:10.1201/b15450 · Cited by 1,068
Tumour and Normal Tissue Responses to Fractionated Non-uniform Dose Delivery
Källman, P., Ågren, A., & Brahme, A. (1992) · International Journal of Radiation Biology · doi:10.1080/09553009214552071 · Cited by 562
Kutcher, G. J., Burman, C., Brewster, L., Goitein, M., & Mohan, R. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90173-2 · Cited by 559
Treatment volume and tissue tolerance
Rodney Withers, H., Taylor, J. M. G., & Maciejewski, B. (1988) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(88)90098-3 · Cited by 445
Kong, F.-M., Hayman, J. A., Griffith, K. A., Kalemkerian, G. P., Arenberg, D., Lyons, S., Turrisi, A., Lichter, A., Fraass, B., Eisbruch, A., et al. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.01.051 · Cited by 336
Self-citationModels in radiotherapy: Volume effects
Schultheiss, T. E., Orton, C. G., & Peck, R. A. (1983) · Medical Physics · doi:10.1118/1.595312 · Cited by 267
Cited by
Radiopharmaceutical therapy in cancer: clinical advances and challenges
Sgouros, G., Bodei, L., McDevitt, M. R., & Nedrow, J. R. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0073-9 · Cited by 963
The linear quadratic model: usage, interpretation and challenges
McMahon, S. J. (2018) · Physics in Medicine & Biology · doi:10.1088/1361-6560/aaf26a · Cited by 440
Dewaraja, Y. K., Frey, E. C., Sgouros, G., Brill, A. B., Roberson, P., Zanzonico, P. B., & Ljungberg, M. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.100123 · Cited by 419
Maier, P., Hartmann, L., Wenz, F., & Herskind, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010102 · Cited by 414
Predicting outcomes in radiation oncology—multifactorial decision support systems
Lambin, P., van Stiphout, R. G. P. M., Starmans, M. H. W., Rios-Velazquez, E., Nalbantov, G., Aerts, H. J. W. L., Roelofs, E., van Elmpt, W., Boutros, P. C., Granone, P., et al. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.196 · Cited by 402
Predicting dose‐volume histograms for organs‐at‐risk in IMRT planning
Appenzoller, L. M., Michalski, J. M., Thorstad, W. L., Mutic, S., & Moore, K. L. (2012) · Medical Physics · doi:10.1118/1.4761864 · Cited by 382
Radiation-Induced Lung Injury (RILI)
Giuranno, L., Ient, J., De Ruysscher, D., & Vooijs, M. A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00877 · Cited by 372
De Ruysscher, D., Faivre-Finn, C., Nestle, U., Hurkmans, C. W., Le Péchoux, C., Price, A., & Senan, S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.3271 · Cited by 364
Vinod, S. K., Jameson, M. G., Min, M., & Holloway, L. C. (2016) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2016.09.009 · Cited by 350
Treatment of late sequelae after radiotherapy for head and neck cancer
Strojan, P., Hutcheson, K. A., Eisbruch, A., Beitler, J. J., Langendijk, J. A., Lee, A. W. M., Corry, J., Mendenhall, W. M., Smee, R., Rinaldo, A., et al. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.07.003 · Cited by 350
Self-citationClinical development of new drug–radiotherapy combinations
on behalf of the NCRI CTRad Academia-Pharma Joint Working Group, Sharma, R. A., Plummer, R., Stock, J. K., Greenhalgh, T. A., Ataman, O., Kelly, S., Clay, R., Adams, R. A., Baird, R. D., et al. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.79 · Cited by 320
Illidge, T., Specht, L., Yahalom, J., Aleman, B., Berthelsen, A. K., Constine, L., Dabaja, B., Dharmarajan, K., Ng, A., Ricardi, U., et al. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.01.006 · Cited by 314
Self-citationAluwini, S., Pos, F., Schimmel, E., Krol, S., van der Toorn, P. P., de Jager, H., Alemayehu, W. G., Heemsbergen, W., Heijmen, B., & Incrocci, L. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00567-7 · Cited by 309
Grégoire, V., & Mackie, T. R. (2011) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2011.04.003 · Cited by 305
Peeler, C. R., Mirkovic, D., Titt, U., Blanchard, P., Gunther, J. R., Mahajan, A., Mohan, R., & Grosshans, D. R. (2016) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2016.11.001 · Cited by 271
Radiomics in radiooncology – challenging the medical physicist
Peeken, J. C., Bernhofer, M., Wiestler, B., Goldberg, T., Cremers, D., Rost, B., Wilkens, J. J., Combs, S. E., & Nüsslin, F. (2018) · Physica Medica · doi:10.1016/j.ejmp.2018.03.012 · Cited by 98
Clinical and epidemiological observations on individual radiation sensitivity and susceptibility
Seibold, P., Auvinen, A., Averbeck, D., Bourguignon, M., Hartikainen, J. M., Hoeschen, C., Laurent, O., Noël, G., Sabatier, L., Salomaa, S., et al. (2020) · International Journal of Radiation Biology · doi:10.1080/09553002.2019.1665209 · Cited by 56
Hobbs, R. F., McNutt, T., Baechler, S., He, B., Esaias, C. E., Frey, E. C., Loeb, D. M., Wahl, R. L., Shokek, O., & Sgouros, G. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.08.022 · Cited by 53
The Role of Preclinical Models in Radiopharmaceutical Therapy
Sgouros, G., Hobbs, R. F., & Abou, D. S. (2014) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2014.34.e121 · Cited by 16
Metadata
- Authors
- Bentzen, S. M., Constine, L. S., Deasy, J. O., Eisbruch, A., Jackson, A., Marks, L. B., Ten Haken, R. K., & Yorke, E. D.
- Venue
- International Journal of Radiation Oncology*Biology*Physics
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 76
- Issue
- 3
- Pages
- S3-S9
- ISSN
- 0360-3016 (ISSN-L)
- OpenAlex
- W2029328961
- Cited by
- 1,257
- References
- 27
- FWCI
- 43.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.